BIOLASE (NASDAQ:BIOL) Receives New Coverage from Analysts at StockNews.com

StockNews.com initiated coverage on shares of BIOLASE (NASDAQ:BIOL) in a research report report published on Thursday. The brokerage issued a sell rating on the medical technology company’s stock.

BIOLASE Stock Performance

Shares of NASDAQ:BIOL opened at $0.15 on Thursday. The business’s 50 day moving average is $0.17 and its 200 day moving average is $0.88. BIOLASE has a 12-month low of $0.13 and a 12-month high of $47.10. The company has a quick ratio of 0.68, a current ratio of 1.26 and a debt-to-equity ratio of 34.06.

BIOLASE (NASDAQ:BIOL) last announced its earnings results on Thursday, March 21st. The medical technology company reported ($1.76) EPS for the quarter. BIOLASE had a negative net margin of 41.97% and a negative return on equity of 555.22%. The firm had revenue of $13.49 million during the quarter.

Institutional Investors Weigh In On BIOLASE

A number of hedge funds have recently modified their holdings of BIOL. Walleye Capital LLC purchased a new position in shares of BIOLASE in the second quarter worth about $100,000. State Street Corp grew its stake in BIOLASE by 4.5% in the 1st quarter. State Street Corp now owns 436,076 shares of the medical technology company’s stock valued at $154,000 after buying an additional 18,682 shares in the last quarter. Renaissance Technologies LLC raised its holdings in BIOLASE by 222.5% during the 1st quarter. Renaissance Technologies LLC now owns 138,848 shares of the medical technology company’s stock valued at $39,000 after acquiring an additional 95,789 shares during the period. Finally, Citadel Advisors LLC purchased a new stake in shares of BIOLASE during the second quarter worth $118,000. Institutional investors own 8.79% of the company’s stock.

BIOLASE Company Profile

BIOLASE, Inc, together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications.